77,973 Shares in ICU Medical, Inc. $ICUI Bought by Nuveen LLC

Nuveen LLC bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 77,973 shares of the medical instruments supplier’s stock, valued at approximately $10,827,000. Nuveen LLC owned 0.32% of ICU Medical at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in ICUI. GAMMA Investing LLC lifted its position in ICU Medical by 17,559.7% during the first quarter. GAMMA Investing LLC now owns 99,424 shares of the medical instruments supplier’s stock worth $138,060,000 after buying an additional 98,861 shares during the period. Point72 Asset Management L.P. lifted its position in ICU Medical by 63.2% during the fourth quarter. Point72 Asset Management L.P. now owns 245,340 shares of the medical instruments supplier’s stock worth $38,069,000 after buying an additional 95,030 shares during the period. Pacific Capital Partners Ltd purchased a new position in ICU Medical during the first quarter worth about $12,845,000. Invesco Ltd. increased its stake in ICU Medical by 80.1% during the first quarter. Invesco Ltd. now owns 203,827 shares of the medical instruments supplier’s stock worth $28,303,000 after acquiring an additional 90,674 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock worth $83,788,000 after acquiring an additional 82,982 shares during the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

ICU Medical Trading Up 5.3%

NASDAQ:ICUI opened at $128.18 on Friday. The company has a quick ratio of 1.17, a current ratio of 2.44 and a debt-to-equity ratio of 0.63. The business’s 50 day moving average is $127.17 and its two-hundred day moving average is $137.05. ICU Medical, Inc. has a 52 week low of $107.00 and a 52 week high of $196.26. The company has a market cap of $3.16 billion, a PE ratio of -84.33 and a beta of 0.88.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $2.10 EPS for the quarter, topping analysts’ consensus estimates of $1.44 by $0.66. ICU Medical had a positive return on equity of 7.24% and a negative net margin of 1.56%.The company had revenue of $543.57 million for the quarter, compared to the consensus estimate of $543.33 million. During the same quarter last year, the business posted $1.56 EPS. ICU Medical’s quarterly revenue was down 8.0% compared to the same quarter last year. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. On average, analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ICUI shares. Piper Sandler started coverage on ICU Medical in a research note on Friday, August 15th. They set an “overweight” rating and a $145.00 price target for the company. Wall Street Zen lowered ICU Medical from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Raymond James Financial lowered their target price on ICU Medical from $187.00 to $180.00 and set a “strong-buy” rating for the company in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $179.00.

Insider Buying and Selling

In related news, CEO Vivek Jain purchased 21,929 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The shares were acquired at an average price of $112.84 per share, with a total value of $2,474,468.36. Following the acquisition, the chief executive officer owned 130,149 shares in the company, valued at approximately $14,686,013.16. This trade represents a 20.26% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Christian B. Voigtlander sold 4,985 shares of ICU Medical stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $128.50, for a total value of $640,572.50. Following the sale, the chief operating officer directly owned 6,088 shares in the company, valued at $782,308. The trade was a 45.02% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.50% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.